SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
293.60    8.20 (2.87%)
Bid:
292.40
Ask:
293.00
Spread: 0.60 (0.205%)
Market Cap: £1.02b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Update

17 Sep 2020 07:00

RNS Number : 2245Z
Breedon Group PLC
17 September 2020
 

 

 

 

 

NEWS RELEASE

17 September 2020

 

 

 

BREEDON GROUP PLC ("Breedon" or "the Group")

Trading Update

 

Trading performance

 

Breedon has continued to deliver an encouraging trading performance since demand began to return in early May after the COVID-19 lockdown, with the improving trend that we reported for June and July at the time of our interim results continuing into August. The Group delivered revenues for the first eight months of the year of £531 million (2019: £624 million), including a one-month contribution from our recently-acquired CEMEX assets in the UK.

 

Outlook

 

The Board has reviewed the latest management forecasts and is now in a position to reinstate guidance for the 2020 financial year. Accordingly, we currently anticipate delivering second-half underlying EBIT broadly in line with the second half of 2019, which would deliver a result in excess of the average of current full-year market expectations.*

 

We continue to be reassured by the Government's restated commitment to investment in the UK's infrastructure and by encouraging demand from the UK housing market, complemented by similar trends in the Republic of Ireland. As a provider of an essential service, we have proved our ability to deliver a resilient performance despite unprecedented disruption, which gives us considerable confidence in the long-term outlook for our business.

 

We plan to issue our customary trading update for the first 10 months of the year on 18 November 2020 and to announce our preliminary results for the year ended 31 December 2020 on 10 March 2021.

 

* The Group believes that the average of current full-year market expectations for underlying EBIT is £57 million, with a range of £49 million to £70 million.

 

- ends -

 

The information contained within this announcement is deemed by the Group to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

 

Note to editors

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. Following the acquisition of a portfolio of CEMEX's UK assets (subject to implementation of the remedies required by the CMA), the Group employs over 3,500 people and has around 1 billion tonnes of mineral reserves and resources. The Group's strategy is to continue growing through organic improvement and the acquisition of businesses in the heavyside construction materials market.

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director 01332 694010

 

Stephen Jacobs, Group Head of Communications 07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley/Harry Hargreaves 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop/Heraclis Economides 020 7260 1000

 

Teneo

Matt Denham/ Rachel Miller 020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNVVRRKUKAAR
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.